Submitted by Anonymous (not verified) on 22 April 2024 - 11:48
Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 24, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 24, Status: Authorised